Technical FAQs
Yes. BOT Bioscience Inc. has extensive experience in preparing antibodies by our proprietary platform. We have developed 10,000+ antibodies against a variety of targets including virus, CD molecules, drug targets, and enzymes.
Yes. All information in our data sheet are the latest data for all products.
Yes, some products can be applied for free samples.
In general, BOT Bioscience provides uniform discounts for bulk orders and some new products.
Clone ID is the internal unique identity number assigned to each mAb clone, while lot number is corresponding to each batch of antibody mass production. The same clone ID can have different lot numbers.
Five isotypes, , including IgA, IgD, IgE, IgG and IgM.
Several methods have been employed for calculating the Ka, e.g. SPR and BLI.
In general, stained cells can be analyzed the following day if they are fixed and stored appropriately. But analysis occurs on the same day for best results.
We does not determine the epitope for most of its antibodies.
Our antibody sequence is confidential and cannot be provided, but we can provide information about the immunogen of the antibody.
The product specific pages and datasheets provide a recommended concentration for each validated application.
Yes, but protein folding or sequence differences in the antibody-binding region can lead to poor (or no) recognition of the standard.
Antibody products cannot be used for treatment, only for scientific research.
For rabbits, we guarantee a minimum titer of 10,000 in at least one animal for all products. For monoclonal antibodies, the titer of different antibodies is also different.
BOT-Bioscience guarantees its antibodies work for the applications and react with the species that listed on the website.
We use 0.01M PBS (pH 7.4).
To produce anti-rabbit IgG affinity purified secondary antibodies, anti-rabbit IgG is passed by a column containing immobilized rabbit IgG.
We recommend you briefly centrifuge the vial to ensure all of the antibody is at the bottom of the tube.
Polyclonal antibodies can recognize a mixture of different epitopes of the antigen.
Usually the synthesized peptide should have similar structure:
Peptides derived from the C terminal with N terminal modified by acetylation.
Peptides derived from the N terminal with C terminal modified by amidation.
Peptides derived from an internal sequence with both ends modified.